Remus Pharma. (REMUS)

FAST GROWER

FairStock Score: 49/100 — MIXED

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹642
Market Cap₹788.35 Cr
P/E Ratio23.53
ROCE19.64%
ROE—%
Dividend Yield0.15%
Profit Growth24.91%
Debt/Equity—
Sales Growth46.77%
Promoter Holding70.95%
52-Week Range₹580 — ₹2,020
SectorPharmaceuticals & Biotechnology

Remus Pharma. trades with a P/E ratio of 23.53, ROCE of 19.64%, profit growth of 24.91%. The FairStock Score of 49/100 suggests mixed fundamentals — some metrics look solid while others need improvement.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer